Resolution of Graves' disease after renal transplantation

Research output: Contribution to journalArticle

Abstract

We report a case of an adolescent boy with Down's syndrome and ESRD on hemodialysis who developed mild Graves' disease that was not amenable to radioablation, surgery, or ATDs. After 14 months of observation without resolution of Graves' disease, he successfully received a DDRT with a steroid minimization protocol. Thymoglobulin and a three-day course of steroids were used for induction and he was started on tacrolimus, MMF, and pravastatin for maintenance transplant immunosuppression. One month after transplantation, all biochemical markers and antibody profiling for Graves' disease had resolved and remain normal one yr later.

Original languageEnglish (US)
Pages (from-to)590-593
Number of pages4
JournalPediatric Transplantation
Volume20
Issue number4
DOIs
StatePublished - Jun 1 2016

Fingerprint

Graves Disease
Kidney Transplantation
Steroids
Pravastatin
Tacrolimus
Down Syndrome
Immunosuppression
Chronic Kidney Failure
Renal Dialysis
Transplantation
Biomarkers
Maintenance
Observation
Transplants
Antibodies

Keywords

  • adolescent
  • Down's syndrome
  • Graves' disease
  • hemodialysis
  • renal transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Resolution of Graves' disease after renal transplantation. / Lee, Yvonne; Butani, Lavjay; Glaser, Nicole; Nguyen, Stephanie.

In: Pediatric Transplantation, Vol. 20, No. 4, 01.06.2016, p. 590-593.

Research output: Contribution to journalArticle

@article{516888ab0fa645f08b11f1412a806445,
title = "Resolution of Graves' disease after renal transplantation",
abstract = "We report a case of an adolescent boy with Down's syndrome and ESRD on hemodialysis who developed mild Graves' disease that was not amenable to radioablation, surgery, or ATDs. After 14 months of observation without resolution of Graves' disease, he successfully received a DDRT with a steroid minimization protocol. Thymoglobulin and a three-day course of steroids were used for induction and he was started on tacrolimus, MMF, and pravastatin for maintenance transplant immunosuppression. One month after transplantation, all biochemical markers and antibody profiling for Graves' disease had resolved and remain normal one yr later.",
keywords = "adolescent, Down's syndrome, Graves' disease, hemodialysis, renal transplantation",
author = "Yvonne Lee and Lavjay Butani and Nicole Glaser and Stephanie Nguyen",
year = "2016",
month = "6",
day = "1",
doi = "10.1111/petr.12709",
language = "English (US)",
volume = "20",
pages = "590--593",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Resolution of Graves' disease after renal transplantation

AU - Lee, Yvonne

AU - Butani, Lavjay

AU - Glaser, Nicole

AU - Nguyen, Stephanie

PY - 2016/6/1

Y1 - 2016/6/1

N2 - We report a case of an adolescent boy with Down's syndrome and ESRD on hemodialysis who developed mild Graves' disease that was not amenable to radioablation, surgery, or ATDs. After 14 months of observation without resolution of Graves' disease, he successfully received a DDRT with a steroid minimization protocol. Thymoglobulin and a three-day course of steroids were used for induction and he was started on tacrolimus, MMF, and pravastatin for maintenance transplant immunosuppression. One month after transplantation, all biochemical markers and antibody profiling for Graves' disease had resolved and remain normal one yr later.

AB - We report a case of an adolescent boy with Down's syndrome and ESRD on hemodialysis who developed mild Graves' disease that was not amenable to radioablation, surgery, or ATDs. After 14 months of observation without resolution of Graves' disease, he successfully received a DDRT with a steroid minimization protocol. Thymoglobulin and a three-day course of steroids were used for induction and he was started on tacrolimus, MMF, and pravastatin for maintenance transplant immunosuppression. One month after transplantation, all biochemical markers and antibody profiling for Graves' disease had resolved and remain normal one yr later.

KW - adolescent

KW - Down's syndrome

KW - Graves' disease

KW - hemodialysis

KW - renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=84966429044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966429044&partnerID=8YFLogxK

U2 - 10.1111/petr.12709

DO - 10.1111/petr.12709

M3 - Article

C2 - 27106887

AN - SCOPUS:84966429044

VL - 20

SP - 590

EP - 593

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

ER -